| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0035-9203(96)90129-7 |
| P698 | PubMed publication ID | 8761583 |
| P2093 | author name string | Wernsdorfer WH | |
| Bygbjerg IC | |||
| Msangeni HA | |||
| Mhina J | |||
| Rønn AM | |||
| P2860 | cites work | The development and spread of drug-resistant malaria | Q39587625 |
| In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected | Q41917730 | ||
| Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals | Q43961974 | ||
| In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination | Q47912389 | ||
| Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa | Q47972356 | ||
| P433 | issue | 2 | |
| P921 | main subject | Tanzania | Q924 |
| pyrimethamine | Q421072 | ||
| Plasmodium falciparum | Q311383 | ||
| P304 | page(s) | 179-181 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | Transactions of the Royal Society of Tropical Medicine and Hygiene | Q15766916 |
| P1476 | title | High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania | |
| P478 | volume | 90 |
| Q49431533 | A brief review on features of falciparum malaria during pregnancy |
| Q41946428 | A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India. |
| Q40564112 | A randomized, double-blind study on the efficacy and safety of a practical three-day regimen with artesunate and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa |
| Q43752870 | A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania |
| Q40497923 | Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community |
| Q38885032 | Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial |
| Q43821540 | Anaemia during pregnancy in southern Tanzania |
| Q43945037 | Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania. |
| Q38881940 | Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial |
| Q40528088 | Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial |
| Q39118502 | Averting a malaria disaster |
| Q40547428 | Chloroquine, sulfadoxine-pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Upper Nile, south Sudan |
| Q41918630 | Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania |
| Q93924997 | Co-trimoxazole in HIV-1 infection |
| Q38805246 | Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies |
| Q54247222 | Comparative effectiveness of malaria prevention measures: a systematic review and network meta-analysis. |
| Q39322857 | Controlling malaria: challenges and solutions |
| Q37363924 | Declining burden of malaria over two decades in a rural community of Muheza district, north-eastern Tanzania |
| Q38958427 | Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania |
| Q34471175 | Do health workers' preferences influence their practices? Assessment of providers' attitude and personal use of new treatment recommendations for management of uncomplicated malaria, Tanzania |
| Q34014169 | Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine |
| Q32156246 | Drug resistance among malaria and other parasites |
| Q39351674 | Drug resistance in malaria parasites of animals and man. |
| Q35129708 | Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania |
| Q41915799 | Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial |
| Q37116879 | Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA) |
| Q37562847 | Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study |
| Q41916246 | Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia |
| Q39564872 | Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial |
| Q39280389 | Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India. |
| Q39736943 | Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad |
| Q30830669 | Epidemiology of drug-resistant malaria |
| Q37289589 | Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania |
| Q36699481 | Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia |
| Q33676392 | Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India |
| Q37781523 | Following the path of most resistance: dhps K540E dispersal in African Plasmodium falciparum |
| Q41916249 | High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations |
| Q28474860 | High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581 |
| Q35545447 | History, dynamics, and public health importance of malaria parasite resistance |
| Q25255530 | How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy |
| Q37433820 | Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research |
| Q38885792 | In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine among schoolchildren in rural Uganda: a comparison between 1995 and 1998. |
| Q24814180 | Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania |
| Q37035200 | Long-term administration of artesunate induces reproductive toxicity in male rats |
| Q40603064 | Malaria diagnosis and treatment administered by teachers in primary schools in Tanzania |
| Q48007457 | Malaria medicines to address drug resistance and support malaria elimination efforts |
| Q34980304 | Malaria risk factors in north-east Tanzania |
| Q34825627 | Malaria: a rising incidence in the United States |
| Q40658843 | Maloprim malaria prophylaxis in children living in a holoendemic village in north-eastern Tanzania |
| Q34885646 | Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania |
| Q28125938 | Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania |
| Q34434822 | Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience |
| Q28475195 | Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria |
| Q41920138 | Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria |
| Q41914168 | Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment |
| Q39103584 | Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania |
| Q36391717 | Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum |
| Q39029567 | Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial |
| Q46605808 | Pyrimethamine/sulfadoxine for treating uncomplicated Plasmodium falciparum malaria in young children in Gabon |
| Q24814023 | Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug |
| Q41923176 | Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania |
| Q39533597 | Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone |
| Q35198733 | Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT) |
| Q41921456 | Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children |
| Q34413590 | Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial |
| Q38885343 | The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda |
| Q43752865 | The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy |
| Q34253706 | Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania |
| Q44445393 | Treatment failure of pyrimethamine‐sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya |
| Q44477861 | Treatment of children with malaria Plasmodium falciparum with derivatives artemisinin |
| Q41917086 | Treatment of uncomplicated malaria in children in Guinea-Bissau with chloroquine, quinine, and sulfadoxine-pyrimethamine |
| Q34515760 | Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence |
| Q33683310 | Using the social entrepreneurship approach to generate innovative and sustainable malaria diagnosis interventions in Tanzania: a case study |
Search more.